Fig. 3From: Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfaBrain MRI at baseline and after approximately two years of treatment with cerliponase alfa. Axial T1-weighted MR images at the level of the lateral ventricles. In patient 1 cerebral atrophy with ex vacuo ventricular dilatation was already present at 42Â months of age (baseline), whereas no cerebral atrophy was present in patient 2 at 48Â months of age after 2Â years of treatment with cerliponase alfaBack to article page